Merck to Buy Caraway Therapeutics in Potential $610 Million Deal
- December 01, 2023
Merck & Co. plans to acquire Caraway Therapeutics in a deal with a potential value of $610 million, the companies jointly announced November 21.
ARTICLE TAGS
You must be logged in to access this content.